retatrutide regulatory approval Demand for Unapproved Weight-Loss Drug Surges on Social Media My thoughts on Retatrutide 🤔🤔

Affordable GLP-1 access with a breakthrough pharmacy solution

Results for Eli Lilly's new Foundayo pill show participants lost 11.1% of their body weight, while results for the company's injectable Zepbound show an average weight loss of 20.2%

Novo Nordisk asserts that these products may contain unapproved or unregulated active pharmaceutical ingredients

Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydn L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T